QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
8.56B
Market cap8.56B
Price-Earnings ratio
21.69
Price-Earnings ratio21.69
Dividend yield
0.63%
Dividend yield0.63%
Average volume
3.80M
Average volume3.80M
High today
$42.31
High today$42.31
Low today
$41.40
Low today$41.40
Open price
$41.82
Open price$41.82
Volume
3.53M
Volume3.53M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

QIAGEN(QGEN) stock is priced at $41.51, giving the company a market capitalization of 8.56B. It carries a P/E multiple of 21.69 and pays a dividend yield of 0.63%.

On 2026-07-10, QIAGEN(QGEN) stock traded between a low of $41.40 and a high of $42.31. Shares are currently priced at $41.51, which is +0.3% above the low and -1.9% below the high.

QIAGEN(QGEN) shares are trading with a volume of 3.53M, against a daily average of 3.8M.

During the past year, QIAGEN(QGEN) stock moved between $32.53 at its lowest and $57.82 at its peak.

During the past year, QIAGEN(QGEN) stock moved between $32.53 at its lowest and $57.82 at its peak.

QGEN News

TipRanks 52m
Goldman Sachs discloses 2.82% stake in QIAGEN via derivatives and shares

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...

TipRanks 52m
Millennium International Management Reports 2.85% Stake in Qiagen

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Benzinga 8h
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover

Private Equity Firms Circle Qiagen The report, citing people familiar with the matter, said the process could also attract additional private equity firms and...

Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover

Analyst ratings

50%

of 20 ratings
Buy
50%
Hold
50%
Sell
0%

More QGEN News

Nasdaq 9h
QGEN Crosses Above Average Analyst Target

In recent trading, shares of Qiagen NV (Symbol: QGEN) have crossed above the average analyst 12-month target price of $41.47, changing hands for $41.99/share. W...

QGEN Crosses Above Average Analyst Target
TipRanks 1d
Qiagen gains after report of early PE interest including EQT, Advent

Shares of Qiagen (QGEN) are trading higher after following reports that the European molecular testing company has drawn early takeover interest from firms incl...

Simply Wall St 5d
How Investors Are Reacting To Qiagen Joining The Russell 1000 Dynamic Index

On 27 June 2026, Qiagen N.V. was added to the Russell 1000 Dynamic Index, bringing the Netherlands-based diagnostics group into a broader benchmark followed by...

How Investors Are Reacting To Qiagen Joining The Russell 1000 Dynamic Index

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.